A carregar...
Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?
Small cell lung cancer (SCLC) is a very aggressive disease, characterised by rapid growth, high response rates to both chemotherapy and radiotherapy and subsequent development of treatment resistance in the vast majority of patients. In the past 30 years, little progress has been made in systemic tr...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070242/ https://ncbi.nlm.nih.gov/pubmed/27843619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2015-000022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|